HDFC Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹1568 Cr | ₹3522 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 31 Dec 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 32% |
Expense Ratio | 2.14 | 1.94 |
Manager | Dhruv Muchhal | Pradeep Kesavan |
ISIN Code | INF179KC1HL7 | INF200K01446 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Month | -5.74% | -5.72% |
6 Month | -1.25% | -0.88% |
1 Year | 21.28% | 13% |
3 Year | - | 22.64% |
5 Year | - | 24.09% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
6 Month | - | - |
1 Year | 13.61% | 13.96% |
3 Year | - | 28.69% |
5 Year | - | 23.74% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Year | 51.48% | 15.04% |
3 Year | - | 17.32% |
5 Year | - | 12.58% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Standard Deviation | - | 13.843% |
Sharp | - | 1.165% |
Beta | - | 0.847% |
Alpha | - | 4.607% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Name | Dhruv Muchhal | Pradeep Kesavan |
Total AUM | ₹520687 Cr | ₹434274 Cr |
Fund Manage | 40 | 43 |
HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 1.98 | 7.82 |
Small Cap | 33.12 | 37.28 |
Large Cap | 32.5 | 30.06 |
Mid Cap | 32.4 | 24.84 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 1.98 | 7.82 |
Pharmaceuticals & Biotechnology | 74.71 | 57.84 |
Healthcare Services | 22.28 | 25.46 |
Retailing | 1.03 | - |
Chemicals & Petrochemicals | - | 3.5 |
Healthcare Equipment & Supplies | - | 5.38 |
Top Comparisons
Nippon India Low Duration Fund- Growth Plan - Growth Option
3Y Returns6.21%
HSBC Low Duration Fund - Regular Growth
3Y Returns6.31%
BANDHAN Focused Equity Fund - Regular Plan - Growth
3Y Returns14.06%
Aditya Birla Sun Life Focused Equity Fund -Growth Option
3Y Returns12.53%
Aditya Birla Sun Life Regular Savings Fund - Growth / Payment - Regular Plan
3Y Returns7.32%
Axis Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns5.69%
Kotak Infrastructure & Economic Reform Fund - Standard Plan-Growth
3Y Returns20.77%
BANDHAN Infrastructure Fund - Regular Plan - Growth
3Y Returns23.79%